{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:55:19Z","timestamp":1790153719573,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ijrobp.2025.03.026","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T16:27:30Z","timestamp":1743092850000},"page":"74-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["High-Dose-Rate Brachytherapy for Vaginal Rhabdomyosarcoma (RMS): Lessons Learned at a Single Institution"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3193-7950","authenticated-orcid":false,"given":"Kaitlyn","family":"Lapen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn R.","family":"Tringale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard H.","family":"Wexler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle N.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil'ad N.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"LaQuaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5234-4134","authenticated-orcid":false,"given":"Suzanne","family":"Wolden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.03.026_bib0001","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1002\/cncr.24465","article-title":"Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005","volume":"115","author":"Ognjanovic","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0002","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejca.2018.12.031","article-title":"Defining and listing very rare cancers of paediatric age: Consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors","volume":"110","author":"Ferrari","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0003","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1200\/JCO.2005.00.554","article-title":"Childhood cancer survival trends in Europe: A Eurocare Working Group study","volume":"23","author":"Gatta","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0004","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/pbc.22928","article-title":"Local control and outcome in children with localized vaginal rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group","volume":"57","author":"Walterhouse","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27096","article-title":"Localized vaginal\/uterine rhabdomyosarcoma\u2014results of a pooled analysis from four international cooperative groups","volume":"65","author":"Minard-Colin","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0006","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ijrobp.2008.01.034","article-title":"Vulval and vaginal rhabdomyosarcoma in children: Update and reappraisal of Institut Gustave Roussy brachytherapy experience","volume":"72","author":"Magn\u00e9","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0007","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1200\/JCO.2010.30.4469","volume":"29","author":"Raney","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0008","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28601","article-title":"Local treatment of rhabdomyosarcoma of the female genital tract: Expert consensus from the Children's Oncology Group, the European Soft-Tissue Sarcoma Group, and the Gooperative Weichteilsarkom Studiengruppe","volume":"70","author":"Lautz","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0009","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.3390\/cancers15215269","article-title":"Rhabdomyosarcoma: Current therapy, challenges, and future approaches to treatment strategies","volume":"15","author":"Zarrabi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/pbc.25252","article-title":"High\u2010dose\u2010rate brachytherapy for vaginal rhabdomyosarcoma using a personalized mold in a 20\u2010month old patient","volume":"62","author":"Hathout","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0011","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1200\/JCO.1990.8.11.1847","article-title":"Long-term sequelae of conservative treatment by surgery, brachytherapy, and chemotherapy for vulval and vaginal rhabdomyosarcoma in children","volume":"8","author":"Flamant","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29600","article-title":"Second cancer risk in childhood cancer survivors treated with intensity\u2010modulated radiation therapy: An updated analysis of more than 10 years of follow\u2010up","volume":"69","author":"Tringale","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0013","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/pbc.24118","article-title":"Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies","volume":"59","author":"Malempati","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0014","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1002\/1097-0142(20010615)91:12<2454::AID-CNCR1281>3.0.CO;2-C","article-title":"What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?","volume":"91","author":"Arndt","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0015","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.3390\/cancers14133247","article-title":"Implementation of image-guided brachytherapy for pediatric vaginal cancers: Feasibility and early clinical results","volume":"14","author":"Terlizzi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0016","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1002\/1097-0142(19931101)72:9<2769::AID-CNCR2820720939>3.0.CO;2-C","article-title":"Aggressive chemotherapy, organ-preserving surgery, and high-dose-rate remote brachytherapy in the treatment of rhabdomyosarcoma in infants and young children","volume":"72","author":"Nag","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0017","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5114\/jcb.2018.79713","article-title":"Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results","volume":"10","author":"Delishaj","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0018","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1200\/JCO.2005.12.096","article-title":"Late effects of pelvic rhabdomyosarcoma and its treatment in female survivors","volume":"23","author":"Spunt","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0019","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijrobp.2010.10.071","article-title":"Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer","volume":"82","author":"Bahng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0020","first-page":"1425","article-title":"Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy","volume":"27","author":"Stahl","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0021","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ijrobp.2019.12.036","article-title":"Outcomes following proton therapy for group III pelvic rhabdomyosarcoma","volume":"106","author":"Indelicato","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.03.026_bib0022","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.radonc.2016.05.013","article-title":"Tumour control and quality of life in children with rhabdomyosarcoma treated with pencil beam scanning proton therapy","volume":"120","author":"Leiser","year":"2016","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625002524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625002524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:38:25Z","timestamp":1777955905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625002524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0360301625002524"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.03.026","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Dose-Rate Brachytherapy for Vaginal Rhabdomyosarcoma (RMS): Lessons Learned at a Single Institution","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}